Brain Oxygenation - Non Invasive Brain Oxygenation
From 01-01-2006 to 31-12-2009
Description
The aim of is to use the measurement of cerebral TOI, FTOE, dCBV and dHBD as a continuous non-invasive monitoring for prevention of cerebral hypoxia. To use the measurement of cerebral TOI, FTOE, dCBV and dHBD as a continuous non-invasive monitoring for prevention of cerebral hypoxia, the following steps are made : a. Further validation of cerebral TOI and FTOE in neonates during cardiac surgery. b. Measurement of the influences of different physiological parameters on cerebral TOI and FTOE c. Measurement of the influences of hypoxic pathology on cerebral TOI and FTOE d; Use of TOI and FTOE as a continuous monitor for prevention of hypoxic brain damage e. Measurement of the cerebral autoregulation by means of measurement of HbD and the invasive blood pressure.Team
- Sabine Van Huffel, Co-promoter
Financing
Funding: FWO - Research Foundation - Flanders
Program/Grant Type: FWO Research Grant - FWO Research Grant
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.
